Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain
Lowell W. Reynolds(Loma Linda University), Dennis M. Fisher(Schlumberger (Ireland)), Everett Heinze(Radiant Research (United States)), Stuart DuPen, Nathaniel P. Katz(Wellesley College), Russell K. Portenoy(Albert Einstein College of Medicine), Mark S. Wallace, Richard Rauck(Carolinas Pain Institute), Steven G. Charapata(University of South Florida), Lynn R. Webster(Adherent Technologies (United States))
Cited by 39
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k
Advances in Neuropathic Pain
|Archives of Neurology|2003|1.2k